Salivary Gland Tumors

Neutron therapy is appropriate for the following histologies:

  • Acinic Cell Carcinoma
  • Adenocarcinoma
  • Adenoid Cycstic Carcinoma
  • Fibroxanthoma, aggressive benign
  • Malignant mixed tumor
  • Mucoepidermoid Carcinoma
  • Pleomorphic Adenoma
  • Carcinoma in ex-Pleomorphic Adenoma
  • Squamous cell carcinoma
Patients who may benefit from neutron therapy include:
  • Newly diagnosed patients with unresectable (inoperable) disease, or residual disease following surgery (positive margins).
  • Patients whose disease has recurred after surgery and/or radiation.
  • Patients who have no residual disease following surgery but are considered at risk for recurrence.

For general questions please contact   Or call 630-840-3865
Security, Privacy, LegalFermi National Accelerator Laboratory

Security, Privacy, Legal